Reduction in Inflammatory Bowel Disease Healthcare During the Coronavirus Disease 2019 Pandemic: A Nationwide Retrospective Cohort Study

Groen, Maarten te; Derks, Monica E.W.; Kuijpers, Chantal C H J; Nagtegaal, Irıs D.; Hoentjen, Frank

doi:10.1053/j.gastro.2020.10.032

Cited by 13 publications

(14 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[1][2][3][4][5][6][7][8][9][10] A recent study describes a decrease in IBD care performed as a result of the pandemic. 22 Due to changes in the healthcare priority, the HRQoL of the patients with IBD may have decreased.…”

Section: Discussionmentioning

confidence: 99%

Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands

Bock

Filipe

Meij

et al. 2021

BMJ Open Gastroenterol

View full text Add to dashboard Cite

ObjectiveCOVID-19 has put a strain on regular healthcare worldwide. For inflammatory bowel disease (IBD), gastrointestinal surgeries were postponed and changes in treatment and diagnostic procedures were made. As abrupt changes in treatment regimens may result in an increased morbidity and consequent well-being of patients with IBD, the aim of this study was to determine the effect of the COVID-19 pandemic on health-related quality of life (HRQoL) in patients with IBD.DesignAll patients with IBD who completed both Inflammatory Bowel Disease Questionnaire (IBDQ) and 36-Item Short Form Health Survey (SF-36) questionnaire between 31 August and 13 September 2020 were included in our cohort study. The primary end point was to determine the HRQoL in patients with IBD, measured by the IBDQ and SF-36 questionnaire. The secondary end point was determining which factors influence the HRQoL in patients with IBD.Results582 patients with IBD filled in the IBDQ and SF-36 questionnaire. The HRQoL in our study population was low according to the questionnaires on both physical and mental subscales. In addition, multivariate analysis showed that increased age, female sex and patients who underwent surgery had a significantly lower HRQoL, most frequently on the physical domains in both questionnaires.ConclusionPatients with IBD had an overall low HRQoL during the COVID-19 pandemic. Furthermore, older patients, women and patients who underwent surgical procedures had the lowest physical HRQoL.

show abstract

Section: Discussionmentioning

confidence: 99%

Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands

Bock

Filipe

Meij

et al. 2021

BMJ Open Gastroenterol

View full text Add to dashboard Cite

show abstract

“…Most of the surgical procedures for benign disease included in the study by Gravesteijn et al do not produce pathology specimens. So similar studies/models for different procedures are needed to assess the impact of the decrease in benign specimens observed in our study, as in the study of Te Groen et al [11]. The procedures involved in the catch-up seen for benign resections of the lower GI-tract in our study might be the follow-up of their results.…”

Section: Discussionmentioning

confidence: 61%

Impact of Corona Pandemic on Numbers in Diagnostic Pathology; A Nationwide Survey in the Netherlands

Velthuysen¹,

Eeden

Cessie

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: The SARS-CoV-2 pandemic has a huge impact on healthcare provided. The nationwide pathology registry of the Netherlands, PALGA, offers an outstanding opportunity to measure this impact for diseases in which pathology examinations are involved. Methods: Pathology specimen numbers in 2020 were compared with specimen numbers in 2019 for 5 periods of 4 weeks, representing two lockdowns and the periods in between, taking into account localization, procedure and dignity of diagnosis.Results: The largest decrease was seen during the first lockdown (spring 2020), when numbers of pathology reports declined up to 88% and almost all specimen types were affected. Afterwards each specimen type showed its own dynamics with a decrease during the second lockdown for some, while for others numbers remained relatively low during the whole year. Generally, for most tissue types resections, cytology and malignant diagnoses showed less decrease than biopsies and benign diagnoses. A significant but small catch-up (up to 17%) was only seen for benign resections of the lower gastro-intestinal tract, malignant skin resections and gallbladder resections.Conclusion: The corona pandemic has a significant effect on pathology diagnostics. This effect was most pronounced during the first lockdown, diverse for different sites of origin and for cytology compared with histology. The data presented here can help to assess the consequences on (public) health and provide a starting point in the discussion on how to make the best choices in times of scarce healthcare resources, considering the impact of both benign and malignant disease on quality of life.

show abstract

“…Regarding the daily care of these patients, telemedicine has now arrived in the field of IBD, with new tools and devices that will enable the development of the forthcoming models of patients care 83,84 . The reduction of endoscopic procedures resulted in a maximum decrease of 46.3% in new diagnoses and in a decrease of 25.5% in indefinite and low‐grade dysplasia diagnoses 85 …”

Section: Covid‐19 In Ibdmentioning

confidence: 99%

“… 83 , 84 The reduction of endoscopic procedures resulted in a maximum decrease of 46.3% in new diagnoses and in a decrease of 25.5% in indefinite and low‐grade dysplasia diagnoses . 85 …”

Section: Covid‐19 In Ibdmentioning

confidence: 99%

COVID‐19 in gastroenterology: Where are we now? Current evidence on the impact of COVID‐19 in gastroenterology

et al. 2021

View full text Add to dashboard Cite

Background The COVID‐19 pandemic has created unprecedented challenges in all fields of society with social, economic, and health‐related consequences worldwide. In this context, gastroenterology patients and healthcare systems and professionals have seen their routines changed and were forced to adapt, adopting measures to minimize the risk of infection while guaranteeing continuous medical care to chronic patients. Objective At this point, it is important to evaluate the impact of the pandemic on this field to further improve the quality of the services provided in this context. Methods/Results/Conclusion We performed a literature review that summarizes the main aspects to consider in gastroenterology, during the pandemic crisis, and includes a deep discussion on the main changes affecting gastroenterology patients and healthcare systems, anticipating the pandemic recovery scenario with future practices and policies.

show abstract

Reduction in Inflammatory Bowel Disease Healthcare During the Coronavirus Disease 2019 Pandemic: A Nationwide Retrospective Cohort Study

Cited by 13 publications

References 6 publications

Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands

Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands

Impact of Corona Pandemic on Numbers in Diagnostic Pathology; A Nationwide Survey in the Netherlands

COVID‐19 in gastroenterology: Where are we now? Current evidence on the impact of COVID‐19 in gastroenterology

Contact Info

Product

Resources

About